What Pharma Needs To Get Right About Privacy In The AI Age

What Pharma Needs To Get Right About Privacy In The AI Age

Leaders in pharma’s AI age won’t be remembered for moving the fastest, but for earning and keeping trust along the way. Privacy will determine which companies pull ahead and which fall behind, making it one of the industry’s biggest tests. The post What Pharma Needs To Get Right About Privacy In The AI Age appeared first on MedCity News.

Pharma sector faces up to AI hurdles

According to FPT Digital, AI and generative AI are creating positive impacts across the global pharmaceutical industry. GenAI is expected to contribute between $60 billion and $110 billion annually from 2024 to 2029. All stages of the pharmaceutical value chain are benefiting from the application of GenAI. Hoang Viet Anh, chairman of FPT Digital, explained that AI supports the development of new drugs by significantly reducing both time and cost…

What Pharma Needs To Get Right About Privacy In The AI Age – RamaOnHealthcare

Leaders in pharma’s AI age won’t be remembered for moving the fastest, but for earning and keeping trust along the way. Privacy will determine which